missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human Lp-PLA2/PLA2G7/PAF-AH ELISA Kit
Click to view available options
Quantity:
5 x 96 Tests
96 Tests
Unit Size:
Each
Pack of 96
Description
Human Lp-PLA2/PLA2G7/PAF-AH quantitates human Lp-PLA2/PLA2G7/PAF-AH in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Lp-PLA2/PLA2G7/PAF-AH.
Platelet Activating Factor (PAF) is a biologically active phospholipid, which exerts primarily proinflammatory activities by specifically signaling through G-protein-coupled receptors on platelets, neutrophils, and monocytes. Platelet Activating Factor Acetylhydrolase (PAF-AH) is a secreted protein that mediates PAF activity by specifically catalyzing hydrolysis of thesn2 ester bond, resulting in the conversion of PAF to the biologically inactive lyso-PAF. PAF-AH can also interact with LDL particles to induce the hydrolysis of LDL-associated, oxidized phospholipids, generating lysophosphatidylcholine (lyso-PC) and other lysophospholipids.
Specifications
Specifications
| Accession Number | 1-alkyl-2-acetylglycerophosphocholine esterase; 2-acetyl-1-alkylglycerophosphocholine esterase; Group-VIIA phospholipase A2; gVIIA-PLA2; LDL-associated phospholipase A2; LDL-PLA(2); LDL-PLA2; lipoprotein-associated phospholipase A2; LP-PLA2; PAF 2-acylhydrolase; PAF acetylhydrolase; PAFAD; PAFAH; phospholipase A2 group VII; phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma); PLA2G7; Platelet-activating factor acetylhydrolase; R75400 |
| Assay Range | 8.19 to 2,000 ng/mL |
| Assay Sensitivity | 8.1 ng/mL |
| Conjugate | HRP |
| Product Type | ELISA |
| Sample Type | Plasma, Serum, Supernatant |
| For Use With (Equipment) | Colorimetric Microplate Reader |
| Gene ID (Entrez) | 7941 |
| Gene Symbol | PLA2G7 |
| Interassay CV | <12% |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction